Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Times Interest Earned (2022 - 2025)

Autolus Therapeutics' Times Interest Earned history spans 4 years, with the latest figure at -$3.17 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 228.98% year-over-year to -$3.17; the TTM value through Dec 2025 reached -$7.38, up 71.6%, while the annual FY2025 figure was -$7.38, 71.6% up from the prior year.
  • Times Interest Earned reached -$3.17 in Q4 2025 per AUTL's latest filing, up from -$6.81 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $8.96 in Q2 2025 to a low of -$21.58 in Q2 2022.
  • Average Times Interest Earned over 4 years is -$6.98, with a median of -$6.39 recorded in 2025.
  • The largest YoY upside for Times Interest Earned was 254.77% in 2025 against a maximum downside of 228.98% in 2025.
  • A 4-year view of Times Interest Earned shows it stood at -$3.37 in 2022, then skyrocketed by 47.53% to -$1.77 in 2023, then surged by 239.15% to $2.46 in 2024, then crashed by 228.98% to -$3.17 in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Times Interest Earned are -$3.17 (Q4 2025), -$6.81 (Q3 2025), and $8.96 (Q2 2025).